@article{Serra_2021, title={Improved efficiency and cost reduction in the emergency department by replacing contemporary sensitive with high-sensitivity cardiac troponin immunoassay: Commentary to the Article on high-sensitivity cardiac troponin immunoassay. Acta Biomed 2019; 90(4):414-620}, volume={92}, url={https://mattioli1885journals.com/index.php/actabiomedica/article/view/9236}, DOI={10.23750/abm.v92i2.9236}, abstractNote={<p>The Authors planned this study to evaluate the impact of replacing a contemporary-sensitive with HS cTnI immunoassay on hospital and laboratory workload. <br>The authors say that, ‘Despite some evidence, the clinicians are still hesitant to replace the former so-called contemporary-sensitive methods with HS-cTn techniques, justifying this reluctance with concerns of overutilization, possible over diagnosis of cardiac injuries, overcrowding of emer-gency departments (EDs), and excess of cardiac invasive testing. Several factors have lead clinicians to use terms such as “troponin leak”, “false-positive” troponin elevation, or “troponinemia”. The results of this study show substantial organizational and economic benefits by replacing con-temporary-sensitive with HS cTnI immunoassays. This is very important question because there are some areas such as acute non-ST elevation coro-nary syndromes (NSTEMI) and in elderly patients, the specificity is very low for the simultaneous presence of factors that can alter the dosage of HS-cTnI values.  </p> <p> </p>}, number={2}, journal={Acta Biomedica Atenei Parmensis}, author={Serra, Walter}, year={2021}, month={May}, pages={e2021183} }